The FDA is loosening its rules on the authorisation of diagnostic tests for the new coronavirus, but it is still some way behind Europe.
The good times continue to roll for big cap device makers, with two companies doubling their market value, and not a single share price fall.
The Dutch group is ripe for a takeover, and while Thermo Fisher has to be the likeliest candidate for acquirer there are a number of potentially interested parties.
Two dental companies go public inside a week, with very different results.
Deal is the fifth largest robotics surgery purchase ever, and the second big move from Stryker.
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.
Vascular robotics is growing fast and Corindus is the leader here, but Healthineers will need an aggressive sales plan.
The deal is 2019’s second-biggest medtech flotation, and the fourth-biggest ever.
Exact Sciences finds that where there’s muck there’s brass, but specialisation does not work as well for Abiomed.